ORIGINAL RESEARCH article
Front. Digit. Health
Sec. Health Technology Implementation
Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1559203
This article is part of the Research TopicAdvances in Artificial Intelligence Transforming the Medical and Healthcare SectorsView all 12 articles
IMPACT OF THE USE OF THE ULTRA-PORTABLE DIGITAL X-RAY WITH CAD4TB FOR ACTIVE CASE FINDING FOR TUBERCULOSIS IN NIGERIA
Provisionally accepted- 1Society for Family Health Nigeria, Lagos, Nigeria
- 2KNCV Nigeria, Abuja, Nigeria
- 3United States Agency for International Development (Nigeria), Abuja, Nigeria
- 4Institute of Human Virology, Abuja, Nigeria
- 5Centre for Integrated Health Programs, Abuja, Nigeria
- 6Stop TB Partnership, Geneva, Switzerland
- 7Federal Ministry of Health, Abuja, Nigeria
- 8University of Calabar, Calabar, Nigeria
- 9University of Calabar Teaching Hospital, Calabar, Nigeria
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The Ultra-portable-digital-Xray (UPDX) with Computer-Aided-Detection (CAD4TB) is a new technology aimed at bringing tuberculosis (TB) screening innovations to hardto-reach communities and strengthen the active case finding (ACF) interventions for TB. As TB control measures remain critical globally and in Nigeria, the country acquired and rolled out 10 UPDX with CAD in 8 states. This study seeks to evaluate the efficiency and impact of the UPDX with CAD4TB for TB case finding in Nigeria.A retrospective cross-sectional study involving the review of records of individuals 4 years and above who had presented for TB screening during ACF activities conducted using the UPDX with CAD4TB between January 2022 and September 2022.Results: A total of 94,694 subjects 4 years and above were screened for TB with an average presumptive TB proportion of 10.84±5.42% and 10% confirmed TB (r=0.684, p=0.03 and r(df) = r 0.867, p=0.001). The Number needed to screen (NNS) to find one TB case in Northern Nigeria was 39 as against an NNS for the South of 37 (x 2 = 108, p=0.25) and correlations (r = -0.422, p=0.17 and r(df) = -0.575, p=0.05). Similarly, a comparison of the number-needed-to-test (NNT) to find one TB case in Northern and Southern Nigeria gave a North total of 4 against a South total of 5 (x 2 = 60, p=0.3), with correlations (r= -0.033, p=0.92 and r(df) = -0.212, p=0.51) respectively.Among the TB cases confirmed, 3.4 % were asymptomatic with cough and fever absent in 18.2% and 83.2% respectively. The average time-to-diagnosis (TTD) was 2.0 ± 1.04 days while the average time-to-treatment (TTT) was 4.2 ± 1.14 days, with 50.6% receiving same day diagnosis, and 34.5%, same day treatment. The cumulative risks of radiation exposure on healthcare workers using UPDX with CAD4TB and adhering to personal protective practices, were found to be low.We documented the usefulness of UPDX with CAD showing a high TB prevalence and test positivity rate, with significant burden of subclinical TB. This has highlighted the need to scale up its use for ACF for TB and select CAD thresholds for both children and adults.
Keywords: Ultra-Portable, Digital Xray, Computer-aided detection, Tuberculosis, Active case finding, Nigeria
Received: 12 Jan 2025; Accepted: 23 May 2025.
Copyright: © 2025 Alege, Useni, Ihesie, Eneogu, Agbaje, Odume, Nongo, Chukwu, Ogbudebe, Oyelaran, Anyomi, Akingbesote, Qin, Barrett, Chijioke-Akaniro, Anyaike and Ewa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Atana Uket Ewa, University of Calabar, Calabar, Nigeria
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.